Literature DB >> 402835

Ultrasonography in pediatric gynecology and obstetrics.

J O Haller, M Schneider, E G Kassner, S J Staiano, M B Noyes, E M Campos, H McPherson.   

Abstract

Sonograms were performed on 144 pediatric patients ranging in age from 2 months to 15 years during a recent 26 month period. The main indications for pelvic sonography were to confirm pregnancy prior to elective abortion; to exclude pregnancy in girls with pelvic masses and/or secondary amenorrhea prior to extensive radiographic studies; to confirm or rule out the presence of pelvic masses; to delineate the extent and internal structure of pelvic tumors; and to exclude ovarian tumors in girls with precocious sexual maturation. Normal sonograms in girls with suspected pelvic tumors usually eliminated the need for additional radiographic studies. Because of technical problems and inherent limitations of present imaging techniques, sonography has an ancillary role in the investigation of patients with abnormal or ambiguous genitalia.

Entities:  

Mesh:

Year:  1977        PMID: 402835     DOI: 10.2214/ajr.128.3.423

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  Pelvic ultrasonography in premenarcheal girls: relation to puberty and sex hormone concentrations.

Authors:  S Salardi; L F Orsini; E Cacciari; L Bovicelli; P Tassoni; A Reggiani
Journal:  Arch Dis Child       Date:  1985-02       Impact factor: 3.791

2.  Diagnostic approach and management of precocious puberty.

Authors:  R A Vaidya
Journal:  Indian J Pediatr       Date:  1982 Mar-Apr       Impact factor: 1.967

3.  Pelvic ultrasonography in pubertal girls.

Authors:  Anju Seth; Anu Aggarwal; K Sandesh; R S Solanki; S Aneja; Guresh Kumar
Journal:  Indian J Pediatr       Date:  2002-10       Impact factor: 1.967

4.  Ultrasonography of the pelvic organs in prepubertal and postpubertal girls.

Authors:  S A Ivarsson; K O Nilsson; P H Persson
Journal:  Arch Dis Child       Date:  1983-05       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.